GASTRITIS
Definition:
inflammation of the gastric or stomach mucosa with mucosal injury. Gastritis may be
*acute, lasting several hours to a few days,
*or chronic, resulting from repeated exposure to irritating agents
*or recurring episodes of acute gastritis
* male to female ratio 1/1
causes:
I- acute gastritis:
*drugs: aspirin, NSAIDs, iron preparation
*H. pylori
*alcohol
*stress: burns, CNS trauma.
*bile reflux
*viral infections: CMV, HS
*radiation
II- chronic non-specific gastritis:
*HP infection
*autoimmune (perniciuos an)
*post-gastrectomy
III- chronic specific gastritis:
*infection, CMV, TB
*Crohn’s disease
*sarcoidosis, GVHD
*idiopathic, granulomatous G
Acute gastitis
definition: an acute mucosal inflammatory process, usually of a transient nature.
*pathophysiology: inflammatory mucosal changes, with neutrophils predomenant.
*symptoms:
1- asymptomatic.
2- dyspepsia, anorexia, nausea,vomiting & hematemesis or malena.
Diagnosis:
1- clinically, no need investigations
2- may need endoscopy & biopsy to exclude PU or cancer.
*Treatment:
1- treat underlying cause
2- symptomatic therapy with antacids, PPIs & antiemetics (e.g. metoclopramide)
Chronic gastritis
Definition:
prolonged inflammation of the stomach.
*Pathophysiology: chararctrised by mononuclear cell infiltrate especially lymphocyte and maccrophages of gastric mucosa
Some types of Ch Gastritis
1- ch g due to HP infection:
*is the most common cause.
*lymphocytes & plasma cells.
* poor correlation between clinical & endoscopic or pathological findings.
*most pt are asymptomatic & managed by modifying patient’s diet& do not require treatment , but if pt develop dyspepsia may benefit from HP eradication.
2- autoimmune ch gastritis:
*it results from autoimmune activity againast parietal cells.
*involves the body of stomach & spares the antrum, characterized by diffuse chronic inflammation, atrophy & loss of fundic glands, intestinal metaplasia & some times hyperplasia of enterochromaffin like cells(ECL).
*Ab to parietal cell & intrinsic factor may be present.
*may be severe lead to pernicious anemia.
3- Menetrier’s disease:
*disease of middle & old age.
*the gastric pits are elongated & tortuous, with replacement of the parietal & chief cells by mucus-secreting cells.
* mostly involve the body & fundus.
*most pt are hypochlorhydric.
*ass with protein losing enteropathy.
*treated with antisecretry drugs or partial gastrectomy.
Peptic ulcer disease (PUD)
Definition:
break in the gastrointestinal mucosa exposed to gastric acid and pepsin, which penetrate the muscularis mucosa, more than 5 mm in diameter may be acute or chronic.
In the acute ulcer, there is no evidence of fibrosis. While in erosion, there is no penetration of muscularis mucosa & less than 5 mm.
*Site:
()lower oesophagus
() stomach ()duodenum
()Jejunum after surgical anastomosis to the stomach
()rarely in the ileum adjacent to a Meckel’s diverticulum.
Gastric & Duodenal ulcer
introduction:
* it’s more common in developing countries& Higher prevalence in low socioeconomic classes
*the lifetime risk for developing a peptic ulcer is approximately 10%
*family history: 3-4 increased risk .
*male/female ratio: DU (5:1 to 2:1) GU (2:1 or less)
*DU usually occur in 30-50 years of age while
*GU usually occur in 50-70 years of age.
* the MR : approximately 1 death per 100,000 cases.
*The hospitalization rate is approximately 30 patients per 100,000 cases.
*ch GU is usually single; 90% on the lesser curve within the antrum or at the junction bet body & antral mucosa.
*ch DU is more than one DU in 10-15% of cases, occur usually in the 1st part of duodenum, 50% on the ant wall .
* GU & DU may coexist in 10% of patients.
Causes
1- H pylori infection
2- Nonsteroidal anti-inflammatory drugs : The gastric mucosa protects itself from gastric acid with a layer of mucus, the secretion of which is stimulated by certain prostaglandins. NSAIDs block the function of cyclooxygenase 1 (cox-1), which is essential for the production of these prostaglandins
3-Smoking: more with GU & less extent to DU.
4-Severe physiologic stress ,Burns , CNS trauma , Surgery
5-Severe medical illnessHypersecretory states (uncommon) , Gastrinoma (Zollinger-Ellison syndrome) or multiple endocrine neoplasia (MEN-I) Antral G cell hyperplasia
Systemic mastocytosis , Basophilic leukemias
6-Diseases associated with an increased risk of PUD include cirrhosis, chronic obstructive pulmonary disease, renal failure, and organ transplantation.
7- Additional rare, miscellaneous causes include radiation-induced or chemotherapy.
pathophysiology
H pylori:
*is G –ve & spiral,
*Has multiple flagella at one end
() make it motile
()allowing it to burrow to live deep Beneath the mucus layer
*has following antigens:
1- adhesin molecule (BabA) which Bind to Lewis b antigen on epith Cells to buffer acidity of stomach By urease enzyme to raise PH.
2- cytotoxin-associated gene (cag A):
Provoke a local inflammatory response in the underlying epithelium by cell replication & apoptosis.
3- vacuolating cytotoxin (vac A) :
*Increase cell permeability,
*efflux of micronutrients from epithelium
*induction of apoptosis
* suppression of local immune cell activity.
4- outer inflammatory protien A(oip A)
* in developed countries, HP infection raise with the age, 50% of people over the age of 50. While in developing countries, affect up to 90% of the adult population.
*HP infections are probably acquired in childhood, the vast majority of colonized people remain healthy & asymptomatic.
*HP responsible for 90% of DU & 70 % of GU
*HP spread by person to person via gastric reflux ate or vomit.
HP & DU
*It’s exclusively colonizes gastric type epithelium & is only found in the duodenum in association with patches of gastric metaplasia, which produce DU by:
1- depletion of antral D-cell(somatostatin)
2- increase gastrin release from G cells
3- increased acid secretion by parietal cells
4- increased acid load in duodenum leads to gastric metaplasia
5- further inflamation & ulceration
Role of H.pylori in GI diseases
Healthy subjects 20-50%
Chronic active gastritis 100%
Duodenal ulcer >90%
Gastric ulcer 70 %
Gastric adenocarcinoma 90%
Gastric lymphoma 85%
Clinical features
()abdominal pain:
*recurrent.
*epigastric
*relation to food
*episodic
*hunger pain
*night pain
()dyspepsia, heartburn, water brash.
()nausea & anorexia
()vomiting (40%)
()silent as anemia from undetected blood loss
()cx as hematemesis or malena or perforation
()the diagnostic value of individual symptoms for PUD is poor
Clinical notes
History
()Patients typically present with abdominal pain that has the following characteristics:
*Epigastric to left upper quadrant
*Frequently described as burning
*May radiate to the back
*Usually occurs 1-5 hours after meals
*May be relieved by food, antacids (duodenal), or vomiting (gastric)
“()Alarm features" that warrant prompt gastroenterology referral are following:
*Bleeding or anemia
*Early satiety
*Unexplained weight loss
*Progressive dysphagia or odynophagia
*Recurrent vomiting
*Family history of GI cancer
()NSAID-induced gastritis or ulcers may be silent.
()Sudden onset of symptoms may indicate perforation.
()Gastritis may present as bleeding, which is more likely in elderly patients.
()Symptoms consistent with anemia (eg, fatigue, dyspnea) may manifest.
Physical
*Epigastric tenderness is present and usually mild.
*Bowel sounds are typically normal.
*Perform a rectal examination and Hemoccult testing.
*Signs of peritonitis may be present with perforation.
*A succussion splash may be present with gastric outlet obstruction
*investigations:
Endoscopy is the preferred investigation.
*in GU , may occasionally malignant & therefore must always be biopsied & follow up.
* investigations for HP are:
()non-invasive: serology
urea breath test
fecal antigen test
()invasive: histology
rapid urea s test
microbiological culture (gold standard)